Autoplaque vs prolaio eVO2peak Module
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if your primary need is a precise, AI-powered quantitative analysis of coronary plaques and luminal stenoses directly from CT angiography images. This tool is ideal for cardiologists and radiologists requiring detailed anatomical insights for heart attack risk prediction and guiding treatment strategies based on plaque characteristics.
View Autoplaque →Choose prolaio eVO2peak Module if…
Choose prolaio eVO2peak Module if you require an efficient, cloud-based solution to estimate peak oxygen consumption using real-world patient data from wearable sensors. This is particularly useful for longitudinal monitoring of cardiovascular fitness, research, or as an adjunctive aid in clinical evaluation where continuous, non-invasive assessment of functional capacity is desired.
View prolaio eVO2peak Module →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | prolaio eVO2peak Module |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | Cloud-based (software-only, processes remote sensor data) |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AutoplaqueAutoplaque (Tool A) is workstation-based and explicitly highlights features like reviewable and editable segmentation, along with detailed Multiplanar Reformatting (MPR) views. This suggests a highly interactive and controllable user experience for clinicians directly manipulating imaging data, which is crucial for diagnostic accuracy and trust. In contrast, Prolaio eVO2peak Module (Tool B) is cloud-based and processes remote sensor data, implying a less interactive, more data-processing-oriented interface.
Clinical Value
TieBoth tools are FDA-cleared and address significant clinical needs in cardiology. Autoplaque (Tool A) provides quantitative anatomical analysis of coronary plaques and stenoses for heart attack risk prediction and treatment guidance. Prolaio eVO2peak Module (Tool B) estimates peak oxygen consumption (eVO2peak) using real-world data, offering a valuable functional assessment for cardiovascular research and care. Both offer strong, albeit distinct, clinical value.
Pricing & Value
TieNeither Autoplaque (Tool A) nor Prolaio eVO2peak Module (Tool B) disclose their pricing information. Without any details on cost, it is impossible to conduct a meaningful comparison of their pricing or assess which offers better value.
Enterprise Readiness
prolaio eVO2peak ModuleProlaio eVO2peak Module (Tool B) explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA), which are critical for enterprise adoption in healthcare. Its cloud-based deployment also generally offers greater scalability and easier management for IT departments. Autoplaque (Tool A), while developed by a major medical center, does not specify HIPAA compliance or BAA, and its workstation-based deployment may present more challenges for large-scale integration and maintenance.
Innovation
prolaio eVO2peak ModuleProlaio eVO2peak Module (Tool B) demonstrates higher innovation by leveraging diverse real-world data from qualified third-party FDA-cleared wearable medical sensors, combined with demographic data, ECG, and accelerometry, processed by a locked deep-learning model to estimate eVO2peak. This approach to continuous, non-invasive physiological assessment using varied data streams is particularly novel. Autoplaque (Tool A) provides advanced AI-powered quantitative analysis of coronary plaques from CT angiography, which, while sophisticated, represents a more established application of AI in medical imaging.
Support & Docs
TieNo information regarding support structures, documentation, or user resources is provided for either Autoplaque (Tool A) or Prolaio eVO2peak Module (Tool B) in the structured facts or readily available through web searches. Therefore, it is not possible to distinguish between the two on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | prolaio eVO2peak Module |
|---|---|---|
| Name | Autoplaque | prolaio eVO2peak Module |
| Company | Cedars-Sinai Medical Center: AIM | Prolaio |
| Primary Function | AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. | Estimates peak oxygen consumption (eVO2peak) using real-world patient data for cardiovascular research and care. |
| Key Analysis/Output | AI-powered quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, measurement of luminal stenoses. | Estimates peak oxygen consumption (eVO2peak). |
| Data Input | CT Angiography images | Demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors. |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and prolaio eVO2peak Module.